This results in inhibition of cell growth, induction of apoptosis, decreased proinflammatory cytokine and vascular growth factor production. MBP. Velcade bortezomib Velcade bortezomib is an antineoplastic agent available for intravenous injection, designed specifically to inhibit proteasomes.